Related Experiment Video
Updated: May 26, 2026
10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
[FDG-PET and endometrial cancer]
Hélène Kolesnikov-Gauthier1, Philippe Carpentier
1Centre Oscar-Lambret, service de médecine nucléaire, Lille Cedex, France. h-gauthier@o-lambret.fr
Bulletin Du Cancer
|December 21, 2011
Summary
Fluorodeoxyglucose-positron emission tomography (FDG-PET) is a valuable tool for many cancers, but its role in endometrial cancer requires further clarification. This review updates current literature to guide clinical opinion and future research directions.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Fluorodeoxyglucose-positron emission tomography (FDG-PET) is established for diagnosing, staging, and monitoring recurrence in various malignancies.
- Currently, there is a lack of standardized recommendations for FDG-PET utilization in endometrial cancer management.
Purpose of the Study:
- To provide a comprehensive update on the existing literature regarding FDG-PET in endometrial cancer.
- To facilitate informed clinical decision-making and opinion formation on the topic.
- To explore potential future applications and research avenues for FDG-PET in this specific gynecologic cancer.
Main Methods:
- Systematic review of current scientific literature.
- Analysis of diagnostic, staging, and recurrence detection data for FDG-PET in endometrial cancer.
- Synthesis of findings to assess clinical utility and identify knowledge gaps.
Main Results:
- FDG-PET shows promise in detecting endometrial cancer, staging disease extent, and identifying recurrence.
- Evidence is still evolving, and comparative studies with conventional imaging are needed.
- Optimal protocols and interpretation criteria for endometrial cancer are under investigation.
Conclusions:
- FDG-PET may offer valuable insights into endometrial cancer management, complementing existing methods.
- Further research is warranted to establish definitive guidelines and optimize its role.
- The potential for FDG-PET in personalized treatment strategies for endometrial cancer is significant.
